Posted July 9, 2013: by Bill Sardi
In the British newspaper The Telegraph, a writer there promotes legislation that is alleged to permit innovation in the war against cancer without penalizing physicians for stepping outside established norms. Twill bet you the proposed law is simply bait for passage of a law that ensures no threat will come to the reigning cancer industry.
Yet, in the words that were penned in The Telegraph, it was also admitted that existing law “obliges the doctor to follow the status quo, even though he/she knows it leads only to poor life-quality followed by death.” The report goes on to say “the current law requires the deceased receive only the ‘standard procedure’ – the endless repetition of a failed experiment.”
Posted in Cancer, Dietary Supplements, Health Care System ; No Comments »
Posted June 25, 2013: by Bill Sardi
The incredible report that doctors in Japan have convincingly cured cancer (see report: IS CANCER BEING CURED RIGHT BEFORE OUR EYES? – Knowledge of Health) speaks loudly for the route by which you are reading this breakthrough. You are not reading about this breakthrough from the American Cancer Society, nor the National Institutes of Health, nor from the American Society of Clinical Oncology, not even The World Health Organization.
Nor has the National Institutes of Health hurried together a press conference on this matter to announce immediate research funding. The FDA has not announced it will mobilize to fast-track this therapy. Nor does the Wall Street crowd make mention of it (the pharmaceutical sector of the markets would crash if this development was to be featured on evening network TV news.)
Someone has said there is more money in treating rather than curing cancer. That is a fact. The American Cancer Society says the tab for cancer care in the world is more than $753 billion annually. To make matters worse, health authorities say cancer care is no longer affordable in developed countries.
Posted in Cancer, Dietary Supplements ; No Comments »
Posted June 21, 2013: by Bill Sardi
In May of 2008 this health writer published an almost unbelievable report of four published studies of 4-7 year remissions from colon and breast cancer facilitated by weekly injection of an abundant sugar-like protein in human blood serum called Gc macrophage activating factor (Gc-MAF). A year later I wrote a follow-up report showing lack of interest by the cancer care community in this remarkable development.
Cancer cells secrete an enzyme called nagalase that completely blocks the conversion of Gc-protein to Gc-MAF which is needed to kill cancer cells via activation of white-blood cells known as macrophages. Macrophages track down and engulf cancer cells.
The startling aspect of these published reports is that the cancer community is ignoring them when there are simply no published studies showing long-term cures for any adult cancers. For example, typical survival for lung and colon cancer is 2-years or less.
Posted in Cancer, Dietary Supplements, Vitamins ; No Comments »
Posted June 20, 2013: by Bill Sardi
Now that we know why naked mole rats are impervious to cancer, the question arises – can we do this for humans?
Naked mole rats (said to be naked because they are hairless) live about ten times longer than any other rodent. But that is not all – they are cancer-proof animals!
The discovery announced today was that a gooey sugar-like substance known as hyaluronan (hyaluronic acid) serves to protect cells in naked mole rats from becoming cancerous.
While all animals produce hyaluronan, which is a water-holding gel in the body, the naked mole rat produces an unusually large (high molecular weight) form of this molecule.
If knowledge is gained how to reproduce this cancer-repellant property in humans, the prospect of cancer-proof humans would be on the horizon.
Posted in Cancer, Dietary Supplements ; No Comments »
Posted June 18, 2013: by Bill Sardi
Defenders of hormone replacement therapy (HRT) now provide evidence that any alleged risks for cancer, stroke, blood clots or other maladies associated with HRT are not greater than those for other commonly-used drugs such as aspirin or statin cholesterol-lowering drugs. Investigators claim risks for these infrequent maladies rise by less than 1 in 1000 HRT-treated women.
What goes unsaid is that while sex hormone mildly increases the risk for breast cancer, dietary modifications can significantly decrease the risk while replacing the estrogen signal in the body.
Researchers recently tested whether estrogen, tamoxifen (a drug anti-estrogen) or a flaxseed diet reduces the production of inflammatory factors called interleukin 1-a and 1-b associated with breast cancer.
Posted in Cancer, Dietary Supplements, Modern Medicine ; No Comments »
Posted June 10, 2013: by Bill Sardi
Mindless medical reporting is rampant in the news media. Biology-trained writers exercise no scrutiny over press releases issued by industry or public health authorities. The public pays the price. A recent example is a news report that says a new drug may avert the need for double mastectomies among breast cancer patients.
In the wake of the disclosure by actress Angelina Jolie that she underwent double-sided mastectomy (removal of both breasts) due to her genetic propensity to develop breast cancer decades in her future, a pharmaceutical company has announced it is pursuing a “breakthrough” to “tackle a faulty gene” that causes this type of cancer. The drug proposes to eliminate the need for double mastectomies. Initial tests conducted among 70 patients produced “impressive responses” to the drug, called BMN673, a drug that targets the BRCA gene.
BMN673 exhibits potent anti-tumor action by inhibition of an enzyme called PARP.
Should women hold their breath now in eager anticipation of this drug?
Posted in Cancer ; No Comments »
Posted May 3, 2013: by Bill Sardi
The anticipation builds for anti-cancer drugs that target a broad array of genes that combat various types of cancer in different organs rather than a different drug for each cancer by their anatomical origin. Instead of anti-cancer drugs for each organ, such as lung, prostate, breast and colon, geneticists now say new drugs in development may address many forms of cancer.
The first examples of this new thinking are studies published in the New England Journal of Medicine showing uterine cancer and leukemia have similar genetic fingerprints and could be treated by the same drug. A large effort to this end is being commandeered at the Cancer Genome Atlas website.
However, the thinking is far too narrow now that geneticists know diseases are integrated via gene networks. An online map can be viewed showing genes in many diseases overlap one another (note: it takes time to load).
Posted in Cancer ; No Comments »
Posted February 13, 2013: by Bill Sardi
Should 500,000 British women (2.4 million U.S. women) take Tamoxifen to prevent breast cancer? A British health agency report (National Institute for Health and Clinical Excellence) says so. Families with a history of breast cancer should also undergo genetic testing, says this same agency.
Tamoxifen was presented by this British health agency as an alternative to having a preventative mastectomy, or breast removal. (However, a recent 20-year study of aged women showed Tamoxifen is no better than mastectomy in regards to survival.)
According to a study, which is not available for examination, 29 cancers and nine deaths could be prevented for every 1,000 women taking tamoxifen for five years. That comes to 1 in 34 Tamoxifen users who would benefit from taking this drug over a 5-year period while subjecting themselves to a long list of potential side effects.
Posted in Cancer, Dietary Supplements ; No Comments »
Posted November 28, 2012: by Bill Sardi
Since the 1970s when Drs. Linus Pauling and Ewan Cameron first utilized intravenous vitamin C to prolong the survival of cancer patients by four-fold, a war has ensued between modern medicine and vitamin C advocates. Mayo Clinic doctors set out to disprove Pauling and employed single-dose oral vitamin C which did not reach sufficient blood concentrations to transiently produce hydrogen peroxide to selectively kill cancer cells. Finally, 28 year later, National Institutes of Health researchers conceded that intravenous vitamin C does indeed kill cancer cells. More recently Drs. Hilary Roberts and Steve Hickey of Manchester, England conclusively showed that even oral doses of vitamin C if taken at frequent intervals could achieve concentrations that can kill cancer cells.
Posted in Cancer, Vitamins ; No Comments »
Posted September 30, 2012: by Bill Sardi
It is not surprising to learn that Big Pharma has shown no interest in what may become the world’s first proven cancer prevention pill. If big profits aren’t promised, pharmaceutical companies predictably pass on such a development.
The pill is a relatively safe FDA-approved generic drug, prescribed millions of times to help control diabetes, and it costs maybe 10-cents a day. But what is surprising is that public health authorities appear to be remiss in announcing this breakthrough. They are the agency in society commissioned to address important public health issues such as this.
Data has been accumulating for 5 years now showing metformin (Glucophage), an anti-diabetic drug, dramatically reduces the risk for cancer and prolongs life among patients who are battling cancer.
Posted in Cancer ; No Comments »
11
17
52
95
14
24
237
6
56
43
10
116
15
66
105